GIE Medical
Plymouth, US · Founded 2018 · 1 known investors
Find your way into GIE Medical
83 people in our graph share verified history with the GIE Medical team — schools, employers, funds. One of them is your warm intro.
John Helmunlockedknows Lixiao Wang · together at University of Wisconsin-Madison (overlapped)
×11knows the team · via University of Wisconsin-Madison
GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel. It is conducting clinical trials in the United States aimed at offering gastroenterology patients sustained patency and fewer repeat treatments.
Founders & leadership
GIE Medical was founded in 2018 by Lixiao Wang.
LW
Lixiao WanginFounder & Chief Executive OfficerLixiao Wang is founder and CEO of GIE Medical, a clinical-stage medical device company developing treatments for benign gastrointestinal strictures. He brings over 30 years of experience in medical device development and leadership.
IS
Ian SchorninChief Operational Officer
JN
James NessChief Financial Officer
HM
Harrison MalinoffVP of Operations and Quality
DH
Dave HendricksonVP of Research & Development
DM
Drew McClureinVP of Market Development
Investors · 1
Reported raises · per SEC filings
Form D private placements$18M disclosed across 3 rounds · 2018–2023
▶$5MraisedSep 2023 · 1 investors · Other Health CareRule 506(b)
▶$5MraisedSep 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ling ShangDirector
- Hui HuDirector
- Ouyang XiangyuDirector
- Lixiao WangExecutive Officer, Director, Promoter
- Rushu LuoDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$11MraisedFeb 2021 · 33 investors · Other Health CareRule 506(b)
▶$11MraisedFeb 2021 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lixiao WangExecutive Officer, Director, Promoter
- Offering amount
- $32.9M
- Amount sold
- $11M
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedAug 2018 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lixiao WangExecutive Officer, Director, Promoter
- Offering amount
- $4.1M
- Amount sold
- $2M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Boston Scientific28 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Laborie20 shared keywordsLaborie develops medical devices and solutions for women's health, including technologies to manage complications like postpartum hemorrhage.
Rf Surgical18 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Bioworld16 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with GIE Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does GIE Medical do?
- GIE Medical is a clinical-stage medical device company developing the ProTractX3, a drug-coated balloon for treating benign strictures of the esophagus and bowel. It is conducting clinical trials in the United States aimed at offering gastroenterology patients sustained patency and fewer repeat treatments.
- Who founded GIE Medical?
- GIE Medical was founded by Lixiao Wang in 2018.
- Who are GIE Medical's investors?
- GIE Medical's investors include HM Venture Partners.
- How much funding has GIE Medical raised?
- GIE Medical has disclosed $18M raised across 3 rounds.
- Where is GIE Medical headquartered?
- GIE Medical is headquartered in Plymouth, US.